+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Scaffold Technology Market By Product Type, By Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 254 Pages
  • July 2022
  • Region: Global
  • Allied Market Research
  • ID: 5670936
The global scaffold technology market was valued at $1,026.0 million in 2021, and is projected to reach $5,095.3 million by 2031, registering a CAGR of 18.0% from 2022 to 2031.

Tissue engineering covers a wide range of applications that repair or replace the portion of damaged tissue. There are three components of tissue engineering such as stem cells, scaffold, and signalizing molecules. Scaffold is used for the growth and development of cells as well as for providing mechanical strength to the cells. Moreover, scaffold-based platforms in 3D cell culture are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth.

In scaffold technology, the cells are grown within extracellular matrix or synthetic materials. Cell adhesion, proliferation, and activation depend on scaffold material properties and scaffold characteristics. To accomplish the required mechanical function and rate of new-tissue formation, different characteristics, such as materials, degradation kinetic, and scaffold properties, should be altered to match the specific application.

Pore distribution, porosity, and exposed surface area of the scaffold can influence the architecture of the extracellular matrix, penetration, rate of penetration of cells, and the final effectiveness of regenerative process. The growth of the global scaffold technology market is majorly driven by rise in demand for body reconstruction procedures and tissue engineering, increase in usage of biomaterials, and growth of technological advancement of scaffold technology.

However, high costs associated with implementation and emergence of scaffold-free technology for cell culturing are expected to hamper the growth of the market. On the contrary, increase in expenditure on R&D by governments in developing countries has high growth potential in these countries.

The scaffold technology market is categorized on the basis of product type, type, application, end user, and region. Depending on product type, the market is divided into natural scaffold and synthetic scaffold. By type, the scaffold technology market is divided into macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds. By application, the market is fragmented into cancer cell research, stem cell research, drug discovery, and regenerative medicine. By end user, the market is classified into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

North America accounted for the largest market share in the viral clearance market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in demand for biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

The report provides a comprehensive competitive analysis of prominent market players such as 3D Biotek LLC, Bico Group, Agilent Technologies, Inc. (Biotek), BioVison Incorporated, Corning Incorporated, Merck KGaA (Sigmaaldrich), PromoCell GmbH, Reprocell, Incorporation, Synthecon, Incorporated, and Thermo Fisher Scientific Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2031, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the scaffold technology market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Market Segments

By Product Type

  • Natural Scaffold
  • Sythetic Scaffold

By Type

  • Macro-Porous Scaffolds
  • Micro-Porous Scaffolds
  • Nano-Porous Scaffolds
  • Solid Scaffolds

By Application

  • Drug discovery
  • Regenerative medicine
  • Cancer cell research
  • Stem cell research

By End User

  • Biotechnology pharmaceutical companies
  • Contract Research laboratories
  • Academic Institutes

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • 3D Biotek, LLC
  • Bico Group
  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • Corning Incorporated
  • InSphero AG
  • Lonza Group Ltd.
  • Synthecon Incorporated
  • Thermo Fisher Scientific Inc.
  • ReproCELL Incorporated
Frequently Asked Questions about the Global Scaffold Technology Market

What is the estimated value of the Global Scaffold Technology Market?

The Global Scaffold Technology Market was estimated to be valued at $1026 million in 2021.

What is the growth rate of the Global Scaffold Technology Market?

The growth rate of the Global Scaffold Technology Market is 17.4%, with an estimated value of $5095.3 million by 2031.

What is the forecasted size of the Global Scaffold Technology Market?

The Global Scaffold Technology Market is estimated to be worth $5095.3 million by 2031.

Who are the key companies in the Global Scaffold Technology Market?

Key companies in the Global Scaffold Technology Market include 3D Biotek, LLC, Bico Group, Avantor, Inc., Becton, Dickinson, and Company, Corning Incorporated, Insphero AG, Lonza Group Ltd., Synthecon Incorporated, Thermo Fisher Scientific Inc. and Reprocell Incorporated.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Natural Scaffold
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Sythetic Scaffold
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SCAFFOLD TECHNOLOGY MARKET, BY TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Macro-Porous Scaffolds
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Micro-Porous Scaffolds
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Nano-Porous Scaffolds
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Solid Scaffolds
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Cancer cell research
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Stem cell research
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug discovery
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Regenerative medicine
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: SCAFFOLD TECHNOLOGY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biotechnology & pharmaceutical companies
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Contract Research laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Academic Institutes
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: SCAFFOLD TECHNOLOGY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product Type
8.2.3 North America Market size and forecast, by Type
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product Type
8.2.6.1.2 Market size and forecast, by Type
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product Type
8.2.6.2.2 Market size and forecast, by Type
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product Type
8.2.6.3.2 Market size and forecast, by Type
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product Type
8.3.3 Europe Market size and forecast, by Type
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product Type
8.3.6.1.2 Market size and forecast, by Type
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product Type
8.3.6.2.2 Market size and forecast, by Type
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 United Kingdom
8.3.6.3.1 Market size and forecast, by Product Type
8.3.6.3.2 Market size and forecast, by Type
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Rest of Europe
8.3.6.4.1 Market size and forecast, by Product Type
8.3.6.4.2 Market size and forecast, by Type
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product Type
8.4.3 Asia-Pacific Market size and forecast, by Type
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product Type
8.4.6.1.2 Market size and forecast, by Type
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product Type
8.4.6.2.2 Market size and forecast, by Type
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product Type
8.4.6.3.2 Market size and forecast, by Type
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product Type
8.4.6.4.2 Market size and forecast, by Type
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 Rest of Asia-Pacific
8.4.6.5.1 Market size and forecast, by Product Type
8.4.6.5.2 Market size and forecast, by Type
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product Type
8.5.3 LAMEA Market size and forecast, by Type
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product Type
8.5.6.1.2 Market size and forecast, by Type
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product Type
8.5.6.2.2 Market size and forecast, by Type
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product Type
8.5.6.3.2 Market size and forecast, by Type
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product Type
8.5.6.4.2 Market size and forecast, by Type
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 3D Biotek, LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Bico Group
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Avantor, Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Becton, Dickinson, and Company
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Corning Incorporated
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 InSphero AG
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Lonza Group Ltd.
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Synthecon Incorporated
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 ReproCELL Incorporated
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 2. Scaffold Technology Market Size, for Natural Scaffold, by Region, 2021-2031 ($Million)
Table 3. Scaffold Technology Market for Natural Scaffold, by Country, 2021-2031 ($Million)
Table 4. Scaffold Technology Market Size, for Sythetic Scaffold, by Region, 2021-2031 ($Million)
Table 5. Scaffold Technology Market for Sythetic Scaffold, by Country, 2021-2031 ($Million)
Table 6. Global Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 7. Scaffold Technology Market Size, for Macro-Porous Scaffolds, by Region, 2021-2031 ($Million)
Table 8. Scaffold Technology Market for Macro-Porous Scaffolds, by Country, 2021-2031 ($Million)
Table 9. Scaffold Technology Market Size, for Micro-Porous Scaffolds, by Region, 2021-2031 ($Million)
Table 10. Scaffold Technology Market for Micro-Porous Scaffolds, by Country, 2021-2031 ($Million)
Table 11. Scaffold Technology Market Size, for Nano-Porous Scaffolds, by Region, 2021-2031 ($Million)
Table 12. Scaffold Technology Market for Nano-Porous Scaffolds, by Country, 2021-2031 ($Million)
Table 13. Scaffold Technology Market Size, for Solid Scaffolds, by Region, 2021-2031 ($Million)
Table 14. Scaffold Technology Market for Solid Scaffolds, by Country, 2021-2031 ($Million)
Table 15. Global Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 16. Scaffold Technology Market Size, for Cancer Cell Research, by Region, 2021-2031 ($Million)
Table 17. Scaffold Technology Market for Cancer Cell Research, by Country, 2021-2031 ($Million)
Table 18. Scaffold Technology Market Size, for Stem Cell Research, by Region, 2021-2031 ($Million)
Table 19. Scaffold Technology Market for Stem Cell Research, by Country, 2021-2031 ($Million)
Table 20. Scaffold Technology Market Size, for Drug Discovery, by Region, 2021-2031 ($Million)
Table 21. Scaffold Technology Market for Drug Discovery, by Country, 2021-2031 ($Million)
Table 22. Scaffold Technology Market Size, for Regenerative Medicine, by Region, 2021-2031 ($Million)
Table 23. Scaffold Technology Market for Regenerative Medicine, by Country, 2021-2031 ($Million)
Table 24. Global Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 25. Scaffold Technology Market Size, for Biotechnology & Pharmaceutical Companies, by Region, 2021-2031 ($Million)
Table 26. Scaffold Technology Market for Biotechnology & Pharmaceutical Companies, by Country, 2021-2031 ($Million)
Table 27. Scaffold Technology Market Size, for Contract Research Laboratories, by Region, 2021-2031 ($Million)
Table 28. Scaffold Technology Market for Contract Research Laboratories, by Country, 2021-2031 ($Million)
Table 29. Scaffold Technology Market Size, for Academic Institutes, by Region, 2021-2031 ($Million)
Table 30. Scaffold Technology Market for Academic Institutes, by Country, 2021-2031 ($Million)
Table 31. Scaffold Technology Market, by Region, 2021-2031 ($Million)
Table 32. North America Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 33. North America Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 34. North America Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 35. North America Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 36. North America Scaffold Technology Market, by Country, 2021-2031 ($Million)
Table 37. U.S. Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 38. U.S. Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 39. U.S. Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 40. U.S. Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 41. Canada Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 42. Canada Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 43. Canada Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 44. Canada Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 45. Mexico Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 46. Mexico Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 47. Mexico Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 48. Mexico Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 49. Europe Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 50. Europe Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 51. Europe Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 52. Europe Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 53. Europe Scaffold Technology Market, by Country, 2021-2031 ($Million)
Table 54. Germany Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 55. Germany Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 56. Germany Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 57. Germany Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 58. France Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 59. France Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 60. France Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 61. France Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 62. United Kingdom Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 63. United Kingdom Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 64. United Kingdom Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 65. United Kingdom Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 66. Rest of Europe Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 67. Rest of Europe Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 68. Rest of Europe Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 69. Rest of Europe Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 70. Asia-Pacific Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 71. Asia-Pacific Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 72. Asia-Pacific Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 73. Asia-Pacific Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 74. Asia-Pacific Scaffold Technology Market, by Country, 2021-2031 ($Million)
Table 75. Japan Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 76. Japan Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 77. Japan Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 78. Japan Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 79. China Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 80. China Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 81. China Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 82. China Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 83. India Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 84. India Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 85. India Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 86. India Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 87. Australia Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 88. Australia Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 89. Australia Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 90. Australia Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 91. Rest of Asia-Pacific Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 92. Rest of Asia-Pacific Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 93. Rest of Asia-Pacific Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 94. Rest of Asia-Pacific Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 95. LAMEA Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 96. LAMEA Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 97. LAMEA Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 98. LAMEA Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 99. LAMEA Scaffold Technology Market, by Country, 2021-2031 ($Million)
Table 100. Brazil Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 101. Brazil Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 102. Brazil Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 103. Brazil Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 104. Saudi Arabia Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 105. Saudi Arabia Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 106. Saudi Arabia Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 107. Saudi Arabia Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 108. South Africa Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 109. South Africa Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 110. South Africa Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 111. South Africa Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 112. Rest of LAMEA Scaffold Technology Market, by Product Type, 2021-2031 ($Million)
Table 113. Rest of LAMEA Scaffold Technology Market, by Type, 2021-2031 ($Million)
Table 114. Rest of LAMEA Scaffold Technology Market, by Application, 2021-2031 ($Million)
Table 115. Rest of LAMEA Scaffold Technology Market, by End-user, 2021-2031 ($Million)
Table 116.3D Biotek, LLC: Company Snapshot
Table 117.3D Biotek, LLC: Operating Segments
Table 118.3D Biotek, LLC: Product Portfolio
Table 119.3D Biotek, LLC: Net Sales
Table 120.3D Biotek, LLC: Key Stratergies
Table 121. Bico Group: Company Snapshot
Table 122. Bico Group: Operating Segments
Table 123. Bico Group: Product Portfolio
Table 124. Bico Group: Net Sales
Table 125. Bico Group: Key Stratergies
Table 126. Avantor, Inc.: Company Snapshot
Table 127. Avantor, Inc.: Operating Segments
Table 128. Avantor, Inc.: Product Portfolio
Table 129. Avantor, Inc.: Net Sales
Table 130. Avantor, Inc.: Key Stratergies
Table 131. Becton, Dickinson, and Company: Company Snapshot
Table 132. Becton, Dickinson, and Company: Operating Segments
Table 133. Becton, Dickinson, and Company: Product Portfolio
Table 134. Becton, Dickinson, and Company: Net Sales
Table 135. Becton, Dickinson, and Company: Key Stratergies
Table 136. Corning Incorporated: Company Snapshot
Table 137. Corning Incorporated: Operating Segments
Table 138. Corning Incorporated: Product Portfolio
Table 139. Corning Incorporated: Net Sales
Table 140. Corning Incorporated: Key Stratergies
Table 141. Insphero Ag: Company Snapshot
Table 142. Insphero Ag: Operating Segments
Table 143. Insphero Ag: Product Portfolio
Table 144. Insphero Ag: Net Sales
Table 145. Insphero Ag: Key Stratergies
Table 146. Lonza Group Ltd.: Company Snapshot
Table 147. Lonza Group Ltd.: Operating Segments
Table 148. Lonza Group Ltd.: Product Portfolio
Table 149. Lonza Group Ltd.: Net Sales
Table 150. Lonza Group Ltd.: Key Stratergies
Table 151. Synthecon Incorporated: Company Snapshot
Table 152. Synthecon Incorporated: Operating Segments
Table 153. Synthecon Incorporated: Product Portfolio
Table 154. Synthecon Incorporated: Net Sales
Table 155. Synthecon Incorporated: Key Stratergies
Table 156. Thermo Fisher Scientific Inc.: Company Snapshot
Table 157. Thermo Fisher Scientific Inc.: Operating Segments
Table 158. Thermo Fisher Scientific Inc.: Product Portfolio
Table 159. Thermo Fisher Scientific Inc.: Net Sales
Table 160. Thermo Fisher Scientific Inc.: Key Stratergies
Table 161. Reprocell Incorporated: Company Snapshot
Table 162. Reprocell Incorporated: Operating Segments
Table 163. Reprocell Incorporated: Product Portfolio
Table 164. Reprocell Incorporated: Net Sales
Table 165. Reprocell Incorporated: Key Stratergies
List of Figures
Figure 1. Scaffold Technology Market Segmentation
Figure 2. Scaffold Technology Market,2021-2031
Figure 3. Scaffold Technology Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Scaffold Technology Market:Drivers, Restraints and Opportunities
Figure 12. Scaffold Technology Market,By Product Type,2021(%)
Figure 13. Comparative Share Analysis of Natural Scaffold Scaffold Technology Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Sythetic Scaffold Scaffold Technology Market,2021-2031(%)
Figure 15. Scaffold Technology Market,By Type,2021(%)
Figure 16. Comparative Share Analysis of Macro-Porous Scaffolds Scaffold Technology Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Micro-Porous Scaffolds Scaffold Technology Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Nano-Porous Scaffolds Scaffold Technology Market,2021-2031(%)
Figure 19. Comparative Share Analysis of Solid Scaffolds Scaffold Technology Market,2021-2031(%)
Figure 20. Scaffold Technology Market,By Application,2021(%)
Figure 21. Comparative Share Analysis of Cancer Cell Research Scaffold Technology Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Stem Cell Research Scaffold Technology Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Drug Discovery Scaffold Technology Market,2021-2031(%)
Figure 24. Comparative Share Analysis of Regenerative Medicine Scaffold Technology Market,2021-2031(%)
Figure 25. Scaffold Technology Market,By End-user,2021(%)
Figure 26. Comparative Share Analysis of Biotechnology & Pharmaceutical Companies Scaffold Technology Market,2021-2031(%)
Figure 27. Comparative Share Analysis of Contract Research Laboratories Scaffold Technology Market,2021-2031(%)
Figure 28. Comparative Share Analysis of Academic Institutes Scaffold Technology Market,2021-2031(%)
Figure 29. Scaffold Technology Market by Region,2021
Figure 30. U.S. Scaffold Technology Market,2021-2031($Million)
Figure 31. Canada Scaffold Technology Market,2021-2031($Million)
Figure 32. Mexico Scaffold Technology Market,2021-2031($Million)
Figure 33. Germany Scaffold Technology Market,2021-2031($Million)
Figure 34. France Scaffold Technology Market,2021-2031($Million)
Figure 35. United Kingdom Scaffold Technology Market,2021-2031($Million)
Figure 36. Rest of Europe Scaffold Technology Market,2021-2031($Million)
Figure 37. Japan Scaffold Technology Market,2021-2031($Million)
Figure 38. China Scaffold Technology Market,2021-2031($Million)
Figure 39. India Scaffold Technology Market,2021-2031($Million)
Figure 40. Australia Scaffold Technology Market,2021-2031($Million)
Figure 41. Rest of Asia-Pacific Scaffold Technology Market,2021-2031($Million)
Figure 42. Brazil Scaffold Technology Market,2021-2031($Million)
Figure 43. Saudi Arabia Scaffold Technology Market,2021-2031($Million)
Figure 44. South Africa Scaffold Technology Market,2021-2031($Million)
Figure 45. Rest of LAMEA Scaffold Technology Market,2021-2031($Million)
Figure 46. Top Winning Strategies, by Year
Figure 47. Top Winning Strategies, by Development
Figure 48. Top Winning Strategies, by Company
Figure 49. Product Mapping of Top 10 Players
Figure 50. Competitive Dashboard
Figure 51. Competitive Heatmap of Top 10 Key Players
Figure 52.3D Biotek, LLC.: Net Sales ,($Million)
Figure 53. Bico Group.: Net Sales ,($Million)
Figure 54. Avantor, Inc..: Net Sales ,($Million)
Figure 55. Becton, Dickinson, and Company.: Net Sales ,($Million)
Figure 56. Corning Incorporated.: Net Sales ,($Million)
Figure 57. Insphero AG.: Net Sales ,($Million)
Figure 58. Lonza Group Ltd..: Net Sales ,($Million)
Figure 59. Synthecon Incorporated.: Net Sales ,($Million)
Figure 60. Thermo Fisher Scientific Inc..: Net Sales ,($Million)
Figure 61. Reprocell Incorporated.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Scaffold Technology Market," the scaffold technology market was valued at $1.02 billion in 2021, and is estimated to reach $5.09 billion by 2031, growing at a CAGR of 18% from 2022 to 2031.

Scaffolds mimic the extracellular matrix of the native tissue, recapitulating the in vivo milieu and allowing cells to influence their own microenvironments. They usually serve purposes such as allow cell attachment and migration, deliver & retain cells and biochemical factors, and exert certain mechanical & biological influences to modify the behavior of the cell phase.

In addition, scaffold can act as a delivery vehicle for exogenous cells and matrix for cell adhesion to facilitate certain unit cell processes (for example, mitosis, synthesis, migration) of cells in vivo or for cells seeded in vitro. It also serves as a barrier to prevent the infiltration of surrounding tissue that may impede the process of regeneration. Scaffold technology technique is gaining popularity in the healthcare research sector, owing to increased demand for body reconstruction procedures and tissue engineering.

Scaffold is a biomaterial that initiates tissue growth in regenerative medicine, and its presence allows cells to generate biological structural components of the extracellular matrix in culture environment. Moreover, natural polymers scaffold shows better fit to the microenvironment of tissues and promotes desirable cellular responses, degradability, and biocompatibility.

Depending on product type, the natural scaffold segment dominated the market in 2021, and is expected to continue this trend throughout the forecast period, owing to growing research in the field of tissue engineering and regenerative medicine to develop novel scaffolds for remodeling of biological tissues.

Based on type, the micro-porous scaffolds segment holds the largest market share, owing to advantages offered by micro-porous scaffold such as high product demand in tissue engineering for liver, bladder, nerve, skin, bone, cartilage, and ligament. Moreover, micro-porous scaffold enables organ-on-a-chip technology to enhance in vivo wound healing. Therefore, this segment is expected to dominate the product segment during the forecast period.

On the basis of application, the regenerative medicine segment is estimated to be the fastest-growing segment during the forecast period owing to successful advancements in regenerative medicine therapies.

Based on end user, the market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment dominated the scaffold technology market size in 2021, registering a CAGR of 18.2% from 2022 to 2031. This growth is attributed to upsurge in collaborations between academic institutions and biotechnology & pharmaceutical companies worldwide.

Several companies collaborate with the laboratories for conducting basic research to eventually reducing the overall time required for the completion of the research. Contract research laboratories segment is expected to grow rapidly by 2031, registering a CAGR of 18.6% during the forecast period, owing to the increased need to provide diagnostic services to biopharmaceutical companies and research laboratories for performing research activities.

By region, North America accounted for the largest market share in 2021, and is anticipated to maintain its dominance from 2022 to 2031 due to the presence of large pharmaceutical and biotechnology companies that use scaffold technology in 3D culture in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and surge in R&D activities focused on technologically advanced solutions are predicted to fuel the adoption of 3D cell culture practices in the region.

In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the scaffold technology market trends. Moreover, strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which is expected to augment the market growth in the coming years.

The report provides a comprehensive analysis of the key players that operate in the global scaffold technology market. The key companies profiled in the report include 3D Biotek LLC, Advanced Biomatrix, Inc., Agilent Technologies, Inc. (Biotek), BioVison, Incorporated, Corning Incorporated, Merck KGaA (Sigmaaldrich), PromoCell GmbH, Reprocell, Incorporation, Synthecon, Incorporated, and Thermo Fisher Scientific Inc.

Key Findings of the Study

  • On the basis of product type, the natural scaffolds segment held 62.86% share in the global Scaffold Technology Market growth in 2021.
  • On the basis of type, the micro-porous scaffolds segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
  • On the basis of application, the cancer research segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
  • On the basis of end user, the academic institutes segment held the largest share in biodegradable scaffold industry in 2021, and is expected to remain dominant throughout the forecast period.
  • Region-wise, North America dominated the scaffold technology market share in 2021, and is expected to be dominant during the forecast period, owing to rise in incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies.

Companies Mentioned

  • 3D Biotek, LLC
  • Bico Group
  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • Corning Incorporated
  • Insphero AG
  • Lonza Group Ltd.
  • Synthecon Incorporated
  • Thermo Fisher Scientific Inc.
  • Reprocell Incorporated

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...